Literature DB >> 20816119

Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study).

Litao Ruan1, Wei Chen, Sathanur R Srinivasan, Jihua Xu, Ahmet Toprak, Gerald S Berenson.   

Abstract

Increased serum phosphorus has been associated with increased mortality from cardiovascular (CV) disease. However, information is scant regarding the influence of serum phosphorus within the normal range on vascular risk in subclinical atherosclerosis in asymptomatic young adults. Serum phosphorus and other CV risk factor variables were measured in 856 white and 354 black subjects without known CV disease or renal disease. Carotid intima-media thickness (IMT) was measured by B-mode ultrasonography. Significant race and gender differences were noted for serum phosphorus (blacks > whites) and carotid IMT (black women > white women; men > women). In bivariate analyses, serum phosphorus was correlated with carotid IMT (p <0.001), and smokers showed higher phosphorus levels than nonsmokers (p = 0.008). In multivariate regression analyses, carotid IMT was significantly associated with serum phosphorus (regression coefficient beta = 0.028, p <0.001) and smoking (beta = 0.032, p <0.001), adjusting for other CV risk factors and estimated glomerular filtration rate. In addition, a significant interaction effect of cigarette smoking and serum phosphorus on carotid IMT was noted, with a greater increasing trend of carotid IMT with phosphorus in smokers than in nonsmokers (p = 0.019 for interaction). In conclusion, serum phosphorus within the normal range is an important correlate of carotid IMT in asymptomatic young adults, with smoking potentiating this adverse association. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816119      PMCID: PMC3103213          DOI: 10.1016/j.amjcard.2010.05.004

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Serum phosphate levels and mortality risk among people with chronic kidney disease.

Authors:  Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2004-12-22       Impact factor: 10.121

2.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; T A Manolio; G L Burke; S K Wolfson
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

3.  Mineral concentrations in the blood of male smokers and non-smoking males and females measured with fluoro-X-ray analyzer.

Authors:  N Sakamoto; K Sakamoto; S Ando
Journal:  Cent Eur J Public Health       Date:  1998-11       Impact factor: 1.163

4.  Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

Authors:  M L Melamed; J A Eustace; L Plantinga; B G Jaar; N E Fink; J Coresh; M J Klag; N R Powe
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

5.  Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

Authors:  Marcello Tonelli; Frank Sacks; Marc Pfeffer; Zhiwei Gao; Gary Curhan
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

6.  The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.

Authors:  Paul J Phelan; Patrick O'Kelly; Joseph J Walshe; Peter J Conlon
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

7.  Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Authors:  Joseph A Vassalotti; Jaime Uribarri; Shu-Cheng Chen; Suying Li; Changchun Wang; Allan J Collins; Mona S Calvo; Adam T Whaley-Connell; Peter A McCullough; Keith C Norris
Journal:  Am J Kidney Dis       Date:  2008-04       Impact factor: 8.860

8.  Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Robert N Foley; Allan J Collins; Areef Ishani; Philip A Kalra
Journal:  Am Heart J       Date:  2008-09       Impact factor: 4.749

9.  Phosphorus levels are associated with subclinical atherosclerosis in the general population.

Authors:  Stephen J Onufrak; Antonio Bellasi; Leslee J Shaw; Charles A Herzog; Francesca Cardarelli; Peter W Wilson; Viola Vaccarino; Paolo Raggi
Journal:  Atherosclerosis       Date:  2008-02-21       Impact factor: 5.162

10.  Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.

Authors:  Ravi Dhingra; Lisa M Sullivan; Caroline S Fox; Thomas J Wang; Ralph B D'Agostino; J Michael Gaziano; Ramachandran S Vasan
Journal:  Arch Intern Med       Date:  2007-05-14
View more
  14 in total

Review 1.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

2.  Sequencing of 2 subclinical atherosclerosis candidate regions in 3669 individuals: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.

Authors:  Joshua C Bis; Charles C White; Nora Franceschini; Jennifer Brody; Xiaoling Zhang; Donna Muzny; Jireh Santibanez; Richard Gibbs; Xiaoming Liu; Honghuang Lin; Eric Boerwinkle; Bruce M Psaty; Kari E North; L Adrienne Cupples; Christopher J O'Donnell
Journal:  Circ Cardiovasc Genet       Date:  2014-06

Review 3.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

4.  Low serum phosphate is associated with ischemic stroke in hemodialysis patients.

Authors:  Tsang-Shan Chen; Chao-Hung Chen; Chien-An Chen; Li-Ping Chou; Chi-Chu Liu
Journal:  Clin Exp Nephrol       Date:  2018-04-20       Impact factor: 2.801

5.  Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study.

Authors:  Angela L Carrelli; Marcella D Walker; Hyesoo Lowe; Don J McMahon; Tatjana Rundek; Ralph L Sacco; Shonni J Silverberg
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

6.  The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.

Authors:  Janeen B León; Catherine M Sullivan; Ashwini R Sehgal
Journal:  J Ren Nutr       Date:  2013-02-08       Impact factor: 3.655

7.  Associations between serum calcium, phosphorus and mortality among patients with coronary heart disease.

Authors:  Qian Chen; Yuan Zhang; Ding Ding; Dan Li; Yunou Yang; Qing Li; Xuechen Chen; Gang Hu; Wenhua Ling
Journal:  Eur J Nutr       Date:  2017-08-14       Impact factor: 5.614

8.  High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice.

Authors:  Asuka Shiota; Yutaka Taketani; Yoichi Maekawa; Koji Yasutomo; Masataka Sata; Tohru Sakai; Risuke Mizuno; Masashi Isshiki; Hironori Yamamoto; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2011-05-25       Impact factor: 3.114

9.  Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide.

Authors:  Yasuhiro Takeuchi; Tatsuhiko Kuroda; Toshitsugu Sugimoto; Masataka Shiraki; Toshitaka Nakamura
Journal:  Calcif Tissue Int       Date:  2015-10-19       Impact factor: 4.333

10.  Associations among total and food additive phosphorus intake and carotid intima-media thickness--a cross-sectional study in a middle-aged population in Southern Finland.

Authors:  Suvi T Itkonen; Heini J Karp; Virpi E Kemi; Elina M Kokkonen; Elisa M Saarnio; Minna H Pekkinen; Merja U M Kärkkäinen; E Kalevi A Laitinen; Maila I Turanlahti; Christel J E Lamberg-Allardt
Journal:  Nutr J       Date:  2013-07-10       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.